ArticleInternational journal of pharmaceutics2017

Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle.

Zilan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.